 Home > Medical News > Latest Medical News > Beida Pharmaceuticals BPI-23314 drug clinical trial application accepted

Beida Pharmaceuticals BPI-23314 drug clinical trial application accepted

 Last Update: 2021-08-16
 Source: Internet
 Author: User

Tags

new type battery

arimidex breast cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On the 29th, Betta Pharmaceuticals announced that it received the "Notice of Acceptance" issued by the NMPA, and the company declared BPI-23314 tablets for the treatment of malignant hematological tumors (including but not limited to myelofibrosis and other myeloproliferative tumors and myelodysplastic syndromes.

BPI-23314 is a new molecular entity with completely independent intellectual property rights independently developed by Betta Pharmaceuticals.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Beida pharmaceutical bpi-23314 drug clinical trial application accepted

01-04

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Beida Pharmaceuticals BPI-23314 drug clinical trial application accepted

Related Articles

Beida pharmaceutical bpi-23314 drug clinical trial application accepted